- Sales:
- Up 6.5% at constant exchange rates
- Including 4.1% organic growth
- Double-digit growth* in 11 countries
- Including: India** (up 28%), China (up 20%), Brazil (up 18%) and Turkey (up 18%)
- Sustained momentum in clinical microbiology, up 8.2%*
- Instrument sales up a robust 7.9%*
Marcy l'Etoile, France - January 24, 2012 - bioMérieux, a world leader in the field of in vitro
diagnostics, today released its business review for fourth-quarter and full-year 2011.
Download
- Filename
- pr_biomerieux__sales_q4_2011_en.pdf
- Size
- 103 KB
- Format
- application/pdf